Write in a clean editor, then format for Frontiers in Cellular and Infection Microbiology in one click — DocuGuru applies the official Frontiers template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Frontiers in Cellular and Infection Microbiology is a peer-reviewed journal published by Frontiers, covering Gut microbiota and health, Antibiotic Resistance in Bacteria, Bacterial biofilms and quorum sensing. Over its lifetime it has published 12,087 papers, which have received 308,276 citations.
| Publisher | Frontiers |
|---|---|
| Reference style | Author–year (Harvard) Author–year — (Smith, 2023) in the text Smith, A., Jones, B. and Lee, C. (2023) 'A representative article title', Frontiers in Cellular and Infection Microbiology, 12(3), pp. 45–58.
Formats any DOI in Frontiers in Cellular and Infection Microbiology style. No sign-up. |
| Publishes research in | Gut microbiota and health Antibiotic Resistance in Bacteria Bacterial biofilms and quorum sensing Clostridium difficile and Clostridium perfringens research Oral microbiology and periodontitis research |
| ISSN | 2235-2988 |
| Citation impact (2-yr) | 4.34 |
| h-index | 183 |
| i10-index | 6,516 |
| Article processing charge | $2,950 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | Chinese Academy of Medical Sciences & Peking Union Medical College |
| Journal website | www.frontiersin.org |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Antimicrobial peptides (AMPs), also known as host defense peptides, are short and generally positively charged peptides found in a wide variety of life forms from microorganisms to humans. Most AMPs have the ability to kill microbial pathogens directly, whereas others act indirectly by modulating the host defense systems. Against a background of rapidly increasing resistance…
Pseudomonas aeruginosa is an opportunistic pathogen affecting immunocompromised patients. It is known as the leading cause of morbidity and mortality in cystic fibrosis (CF) patients and as one of the leading causes of nosocomial infections. Due to a range of mechanisms for adaptation, survival and resistance to multiple classes of antibiotics, infections by P. aeruginosa…
The gut microbiota influences the health of the host, especially with regard to gut immune homeostasis and the intestinal immune response. In addition to serving as a nutrient enhancer, L-tryptophan (Trp) plays crucial roles in the balance between intestinal immune tolerance and gut microbiota maintenance. Recent discoveries have underscored that changes in the microbiota modulate…
Klebsiella pneumoniae is a Gram-negative pathogen that has a large accessory genome of plasmids and chromosomal gene loci. This accessory genome divides K. pneumoniae strains into opportunistic, hypervirulent, and multidrug-resistant groups and separates K. pneumoniae from two closely related species, K. variicola and K. quasipneumoniae. Some strains of K. pneumoniae act as opportunistic pathogens, infecting…
Acinetobacter baumannii is undoubtedly one of the most successful pathogens responsible for hospital-acquired nosocomial infections in the modern healthcare system. Due to the prevalence of infections and outbreaks caused by multi-drug resistant A. baumannii, few antibiotics are effective for treating infections caused by this pathogen. To overcome this problem, knowledge of the pathogenesis and antibiotic…
